Last reviewed · How we verify

Placebo and zolpidem — Competitive Intelligence Brief

Placebo and zolpidem (Placebo and zolpidem) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sedative-hypnotic (non-benzodiazepine). Area: Neurology / Sleep Medicine.

marketed Sedative-hypnotic (non-benzodiazepine) GABA-A receptor (alpha-1 subunit selective) Neurology / Sleep Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Placebo and zolpidem (Placebo and zolpidem) — Takeda. Zolpidem is a sedative-hypnotic that binds to GABA-A receptors in the brain to promote sleep onset and maintenance.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Placebo and zolpidem TARGET Placebo and zolpidem Takeda marketed Sedative-hypnotic (non-benzodiazepine) GABA-A receptor (alpha-1 subunit selective)
Zolpidem + PAP therapy Zolpidem + PAP therapy VA Office of Research and Development marketed Sedative-hypnotic (non-benzodiazepine) + mechanical airway support device GABA-A receptor (zolpidem component); mechanical airway (PAP component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sedative-hypnotic (non-benzodiazepine) class)

  1. Takeda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo and zolpidem — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-and-zolpidem. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: